Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | GAPDH | P04406 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11973070 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL11651644 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL4303631 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL25181805 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL5945372 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL25171260 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL10552173 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL19263699 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL10899501 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 | |
| SCHEMBL10705046 | 0.98 | TSHR (0.48) | TSHRSMN1; SMN2OPRM1LMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618844-B2 | Cancer | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2026-05-05 | — | — | US | claimed |
| EP-3478652-B1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | BOE TECHNOLOGY GROUP CO LTD (CN) | 2024-02-07 | — | — | EP | claimed |
| US-20230068371-A1 | CANCER | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-03-02 | — | — | US | claimed |
| CN-115280150-A | Cancer treatment | 帝国学院创新有限公司 | 2022-11-01 | — | — | CN | claimed |
| EP-3478652-A1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | Boe Technology Group Co. Ltd. (CN) | 2019-05-08 | — | — | EP | claimed |
| US-20180215695-A1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2018-08-02 | — | — | US | claimed |
| CN-104109064-B | A kind of method of ethylene oligomerization | 中国石油化工股份有限公司 | 2018-03-02 | — | — | CN | claimed |
| WO-2018000723-A1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2018-01-04 | — | — | WO | claimed |
| CN-106083573-A | Organic ligand and preparation method, quantum dot, quantum dot layer and Light-Emitting Diode | 京东方科技集团股份有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-104447161-B | Ethylene oligomerization method | 中国石油化工股份有限公司 | 2016-09-21 | — | — | CN | claimed |
| CN-104418690-B | A kind of method of ethylene oligomerization | SINOPEC CORP. (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-104557372-B | A kind of method of ethylene oligomerization | SINOPEC CORP. (CN) | 2016-03-30 | — | — | CN | claimed |
| CN-104628503-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2015-05-20 | — | — | CN | claimed |
| CN-104628502-A | Oligomerization method of ethylene | CHINA PETROLEUM & CHEMICAL | 2015-05-20 | — | — | CN | claimed |
| CN-104557372-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2015-04-29 | — | — | CN | claimed |
| CN-104447161-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2015-03-25 | — | — | CN | claimed |
| CN-104418690-A | Method for oligomerization of ethylene | CHINA PETROLEUM & CHEMICAL | 2015-03-18 | — | — | CN | claimed |
| CN-104109064-A | Ethylene oligomerization method | CHINA PETROLEUM & CHEMICAL | 2014-10-22 | — | — | CN | claimed |
| US-5194415-A | Titanium Trichloride, Polymerization Catalysts | PHILLIPS PETROLEUM COMPANY (US) | 1993-03-16 | — | — | US | claimed |
| EP-0498230-A2 | Polymers of 3-ethyl-1-hexene | PHILLIPS PETROLEUM COMPANY (US) | 1992-08-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180215695-A1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | L1CAM, NECTIN4, CD2 | TSHR 827/4885SMN1; SMN2 3941/4885OPRM1 350/4885 |
| US-12618844-B2 | Cancer | FABP2, CA12, CA13 | TSHR 1899/4885SMN1; SMN2 1598/4885OPRM1 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.